24.07.2021 | COVID-19 | Letter to the Editor
Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis
Erschienen in: Annals of Hematology | Ausgabe 4/2022
Einloggen, um Zugang zu erhalten